Status:
RECRUITING
Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction
Lead Sponsor:
Harbin Medical University
Conditions:
Intravascular Imaging and Microvascular Obstruction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a prospective, single-center, randomized controlled clinical trial. Ninety patients with anterior wall ST-segment elevation myocardial infarction (STEMI) who are planned for primary perc...
Eligibility Criteria
Inclusion
- Clinical
- Subjects aged ≥18 years;
- Initial diagnosis of anterior wall ST-segment elevation myocardial infarction, with symptoms occurring within 6 hours, and undergoing primarypercutaneous coronary intervention (PCI);
- Subjects (or legal representatives) who understand the study requirements and treatment procedures and provide signed informed consent.
- Imaging Inclusion Criteria (Visual Estimation):
- Target lesion is the culprit lesion, located in the native coronary artery, with a visually estimated reference vessel diameter (RVD) between 2.25 mm and 4.0 mm;
- Culprit segment of the infarct-related artery (IRA) is located between the origin of the left anterior descending (LAD) artery and the emergence of the second diagonal branch (D2);
- After pre-treatment , the degree of stenosis in the LAD is ≤90%, and TIMI flow is grade 3.
Exclusion
- Clinical
Key Trial Info
Start Date :
December 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06154395
Start Date
December 20 2023
End Date
June 30 2025
Last Update
October 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China